(2R,3S,4R,4aS)-2,3,7-trihydroxy-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one
Structure Info
- Chemspace ID
- CSSB14929136841 (In-Stock Building Blocks)
- MFCD
- MFCD35203263
- IUPAC Name
- (2R,3S,4R,4aS)-2,3,7-trihydroxy-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one
- Mol formula
- C20H23NO12
- Mol weight
- 469 Da
- Catalog Number(s)
- 141544-37-8, AA024FX6, ACM141544378, AG024FZY, AR024GOY, BD02391012, EC024I5Q, H62926, HY-N12245, OR1105281, TX024H5M, Y4003259, ZXC322459
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -2.69
- Heavy atoms count
- 33
- Rotatable bond count
- 3
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.55
- Polar surface area (Å)
- 208
- Hydrogen bond acceptors count
- 12
- Hydrogen bond donors count
- 8
![Chemical structure of (2R,3S,4R,4aS)-2,3,7-trihydroxy-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one (C20H23NO12) - CSSB14929136841](/st/structure/200/a95b3176eb440e32a1de7ed7ec83cc9e/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528O%255BC%2540H%255D2%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529C%253DC3%255BC%2540%2540H%255D2NC%2528%253DO%2529c2c%2528O%2529c4OCOc4cc32%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png "C20H23NO12")
- Zoom the structure
- CSSB14929136841
Items Overall 5 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Astatech Inc | 2 days | United States To: | 95 | 1 mg | 437.80 | |
Description: NARCICLASINE-4-O-BETA-D-GLUCOPYRANOSIDE; CAS: 141544-37-8 | ||||||
| Angene International Limited | 10 days | China To: | 98 | 5 mg | 557.10 | |
Description: Narciclasine-4-O-β-D-glucopyranoside; CAS: 141544-37-8 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 5 mg | 622.15 | |
| eNovation CN | 20 days | China To: | 98 | 5 mg | 799.25 | |
Description: Narciclasine-4-O--D-glucopyranoside; CAS: 141544-37-8 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 98 | 5 mg | 872.30 | |
Description: Narciclasine-4-O-β-D-glucopyranoside; CAS: 141544-37-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of (2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB00102419905](/st/structure/200/b1977f4eca163d0e0ed864870d368785/O%255BC%2540H%255D1C%253DC2%255BC%2540%2540H%255D%2528NC%2528%253DO%2529C3%253DC%2528O%2529C4%253DC%2528OCO4%2529C%253DC23%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of 2,3,4,7-tetrahydroxy-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB00159267986](/st/structure/200/221203ea1775fbb5db469e75ce936fb0/OC1C%253DC2C%2528NC%2528%253DO%2529C3%253DC%2528O%2529C4%253DC%2528OCO4%2529C%253DC23%2529C%2528O%2529C1O.png)
![Chemical structure of 12-methoxy-13-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5,10,17-tetraoxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),11(19),12,14-hexaene-9,16-dione - CSSB00159261270](/st/structure/200/b613e9a1a89241f19b000fec43f5ce2e/COC1%253DC%2528O%255BC%2540%2540H%255D2O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D2O%2529C%253DC2C%2528%253DO%2529OC3%253DC4OCOC4%253DCC4%253DC3C2%253DC1OC4%253DO.png)
![Chemical structure of (7S)-5-hydroxy-2,8,8-trimethyl-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H,6H,7H,8H-pyrano[3,2-g]chromen-4-one - CSSB00020666987](/st/structure/200/c8c190b5a1d7ebe63cfd21109d5e77d8/CC1%253DCC%2528%253DO%2529C2%253DC%2528O%2529C3%253DC%2528OC%2528C%2529%2528C%2529%255BC%2540H%255D%2528C3%2529O%255BC%2540%2540H%255D3O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D3O%2529C%253DC2O1.png)
![Chemical structure of 1-hydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalene-2-carboxylic acid - CSSB00159262205](/st/structure/200/ae1b1593e978710a2a0ff60ee45d5a41/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC2%253DCC%2528C%2528O%2529%253DO%2529%253DC%2528O%2529C3%253DCC%253DCC%253DC23%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of 5-hydroxy-2,8,8-trimethyl-7-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H,6H,7H,8H-pyrano[3,2-g]chromen-4-one - CSSB02531768677](/st/structure/200/32abbb17d1442a38eb67af14d660bb6c/CC1%253DCC%2528%253DO%2529C2%253DC%2528O%2529C3%253DC%2528OC%2528C%2529%2528C%2529C%2528C3%2529O%255BC%2540%2540H%255D3OC%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529C3O%2529C%253DC2O1.png)
![Chemical structure of N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide - CSSB06256079875](/st/structure/200/5f4580f46b62faed4f0795fcd7125424/CC%2528%253DO%2529N%255BC%2540H%255D1%255BC%2540H%255D%2528O%255BC%2540H%255D2%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540%2540H%255D%2528O%255BC%2540H%255D%2528%255BC%2540H%255D%2528O%2529CO%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529C%253DO%2529%255BC%2540%2540H%255D2O%2529O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O%255BC%2540%2540H%255D1O%255BC%2540H%255D%2528CO%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D1O.png)
